![Eric Falcand](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Falcand
Vorstandsvorsitzender bei Neopharmed Gentili SpA
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Alessandro del Bono | M | - |
Neopharmed Gentili SpA
![]() Neopharmed Gentili SpA Pharmaceuticals: MajorHealth Technology Neopharmed Gentili SpA is a holding company, which engages in the production and sale of pharmaceutical products. the firm includes development and marketing of therapeutic solutions in vascular, cardio-metabolic, respiratory, antibiotic, and over-the-counter medications. Its products include drugs, medical devices, food supplements, and cosmetics. The company was founded in 2009 and is headquartered in Milan, Italy. | - |
Jean-Christophe Tellier | M | 65 |
Servier Laboratories
![]() Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | - |
Laurent Perret | M | - |
Servier Laboratories
![]() Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Marc Ladreit de Lacharrière | M | 83 |
Synthélabo SA
![]() Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | 5 Jahre |
Eliseo Salinas | M | 69 |
Synthélabo SA
![]() Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | 2 Jahre |
Jean-Pierre Charlet | M | 71 |
Synthélabo SA
![]() Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | 3 Jahre |
Jean Michel Demeure | M | 62 |
Synthélabo SA
![]() Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | 8 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Frankreich | 6 | 85,71% |
Italien | 1 | 14,29% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Eric Falcand
- Persönliches Netzwerk